Medicine and Dentistry
Antibody-Drug Conjugate
52%
Folate Receptor 1
47%
B Cell
47%
Guanosine Triphosphatase
47%
B-Cell Chronic Lymphocytic Leukemia
47%
Triple Negative Breast Cancer
47%
Antifolate
47%
Antibody Therapy
47%
Proteochondroitin Sulfate
47%
DNA
47%
Melanoma
47%
B Lymphocyte Receptor
35%
Leukemia Cell
23%
Therapeutics
22%
Neoplasm
21%
In Vitro
19%
Immunoglobulin G1
15%
Xenograft
14%
Microenvironment
11%
Disease Exacerbation
11%
Kinase
11%
Receptor
11%
Cell Growth
10%
Cancer Cell
10%
Patient
10%
Tumor Xenograft
10%
Breast Cancer
10%
Immunocompetent Cell
10%
RNAI
10%
Therapeutic Procedure
9%
Toxicity
9%
Analysis
5%
Cancer Therapy
5%
Neoadjuvant Chemotherapy
5%
Growth Regulation
5%
Association
5%
Mediator
5%
Folate Metabolism
5%
Methylenetetrahydrofolate Reductase
5%
Immunity
5%
Src Inhibitor
5%
Cancer Pathobiology
5%
Metastatic Carcinoma
5%
Volunteer
5%
Overall Survival
5%
Minimal Residual Disease
5%
Immunology and Microbiology
B Cell
94%
Immunoglobulin E
87%
Xenograft
65%
Molecular Imaging
47%
Antibody Structure
47%
Antibody Engineering
47%
Isotype
36%
Leukemia Cell
31%
Mass Spectrometry
18%
Effector Cell
16%
Humoral Immunity
13%
Type I Hypersensitivity
9%
Chimeric Antigen Receptor T-Cell Therapy
9%
Graft-Versus-Host Disease
9%
CRISPR/Cas9
9%
Affinity Maturation
6%
Liver
6%
Somatic Hypermutation
6%
Memory B Cell
6%
Cell Lineage
6%
Pharmacology, Toxicology and Pharmaceutical Science
Antibody Drug Conjugate
100%
Antibody Structure
47%
Folic Acid Antagonist
47%
Chemotherapy
10%
Saporin
9%
Antitumor Activity
9%
Cell Death
5%
